Latest European Patent Convention Stories
GELNHAUSEN, Germany, April 15, 2015 /PRNewswire/ - The patent infringement dispute between Litens and Dayco in Germany regarding the Dayco belt tensioners ATB2007, ATB2253 and the belt tensioners
BRUSSELS and MUNICH, February 26, 2015 /PRNewswire/ -- - Patent filings at the European Patent Office (EPO) reach all-time high in 2014
LEXINGTON, Mass., Feb.
Ruling Prevents Sale of Infringing BMC Masks in Germany MUNICH, Germany and SAN DIEGO, Calif., Feb.
MUNICH, January 22, 2015 /PRNewswire/ -- - Europe's most prestigious innovation prize celebrates its tenth year - The European Patent Office to present
BEIJING, Dec. 1, 2014 /PRNewswire/ -- BMC Medical Co., Ltd. and 3B Medical, Inc.
MONCHENGLADBACH, Germany and NINGBO, China, Nov. 27, 2014 /PRNewswire/ -- Ningbo Signatronic Technologies, Ltd., and TaLa UG & Co.
MELBOURNE, Australia and BARCELONA, October 31, 2014 /PRNewswire/ -- Multigate Medical Devices Pty Ltd (Multigate) was found to infringe two Australian patents of B.
TAIPEI, July 29, 2014 /PRNewswire/ -- Apex Medical Corporation (Apex, TWSE: 4106), a leading player in the Respiratory Therapy and Pressure Area Care sectors, announces that it is appealing
The OncoMouse or Harvard Mouse is a type of laboratory mouse that has been genetically modified utilizing modification designed by Philip Leder and Timothy A. Stewart, of Harvard University, to carry a certain gene called an activated oncogene. The activated oncogene considerably increases the mouse’s vulnerability to cancer, therefore making the mouse suitable for cancer research. The rights to the invention were owned by DuPont until recently. The USPTO found that the patent expired in...
- A serpent whose bite was fabled to produce intense thirst.